80 years of trials and hardships, the inheritance and responsibility of red pharmaceutical enterpri

Mondo Culture Updated on 2024-01-29

In 1943, in a few simple houses, the predecessor of the first pharmaceutical factory of our party and our army was born. Later, the highly-anticipated pharmaceutical factory was named "Xinhua", which means that "the new China will replace the old China".

In the past 80 years, China in the new era has become proud of the world. Over the past 80 years, Xinhua Pharmaceutical has also created many firsts, created countless miracles, and witnessed and promoted the development of the pharmaceutical industry in New China.

Whether it is a pharmaceutical team of 18 people at the beginning, or a modern pharmaceutical company with an annual revenue of 7.5 billion yuan;Whether it was during the War of Resistance Against Japanese Aggression, or in the face of "5"12 National Congress" and the new crown epidemic, Xinhua Pharmaceutical has always put people's lives and health in the first place, and practiced the responsibility and responsibility of a "red pharmaceutical company".

01 was born, striving for New China

At the beginning of its establishment, Xinhua Pharmaceutical was pinned on high hopes.

In 1943, during the critical period of the War of Resistance Against Japan, the Japanese invaders carried out a complete blockade of the Eighth Route Army, and the supply routes to the Jiaodong anti-Japanese base area were all cut off, and there was a shortage of military drugs and medical equipment, and it was urgent to establish the Eighth Route Army's own drug and medical equipment production institutions.

In November of that year, 18 soldiers of the Eighth Route Army, who had a certain medical knowledge base, were ordered to form a pharmaceutical team in Muping County to develop and produce medicines. After that, the pharmaceutical team was relocated several times, the personnel continued to expand, the production scale also expanded, and gradually grew into Xinhua Pharmaceutical Factory, which made a non-negligible contribution to the victory of the War of Resistance against Japanese Aggression and the War of Liberation.

In that arduous war period, Xinhua Pharmaceutical broke through many difficulties and grew firmly.

In 1945, tablets were produced with hand-cranked tablet presses, and in 1946, Xinhua Pharmaceutical became the only pharmaceutical factory founded by our party that could produce preparations, meeting more than 60% of the military needs of medicines, medical equipment and sanitary materials in the Jiaodong Military Region.

On the eve of the founding of the People's Republic of China, Xinhua Pharmaceutical moved from Yantai to Zibo, and set up business offices in Jinan, Yantai, Weixian, Qingdao and Xuzhou, and set up offices in Shanghai and Tianjin. Xinhua Pharmaceutical, whose production target has shifted from military to civilian, has planted the seeds of the pharmaceutical industry in Shandong, and it only takes time for it to grow into a towering tree.

In the 50s of the last century, the Ministry of Chemical Industry determined that Xinhua Pharmaceutical Factory took antipyretic and analgesic drugs as the development direction, and Xinhua Pharmaceutical became the national production base of antipyretic and analgesic drugs, laying the foundation for later becoming an important global production and export base of antipyretic and analgesic drugs.

In 1950, Xinhua Pharmaceutical successfully developed sodium antimony gluconate to extinguish kala-azar in one fell swoopIn 1953, the first glass-lined reaction tank in New China was developedIn 1955, China's first large-scale chemical synthesis API workshop was built - a phenaxitine workshop with an annual output of 100 tonsIn 1963, the Analgin workshop with an annual production capacity of 100 tons was completed and put into operationIn 1985, "Xinhua" brand pyridoxine tablets were used as a new type of norethindrone chemically synthesized antibacterial drugs exclusively produced in China, filling the gap in domestic medicine. Countless firsts have witnessed the growth of Xinhua Pharmaceutical.

Xinhua Pharmaceutical, which has repeatedly made miraculous achievements, has also sent a large number of cadres and technicians to assist in the construction of large national backbone pharmaceutical enterprises such as North China Pharmaceutical and Northwest Second Synthetic Pharmaceutical, laying the foundation for the development of China's chemical and pharmaceutical industry and creating a new era of chemical and pharmaceutical industrialization in New China.

Today, Xinhua Pharmaceutical has a number of product lines such as pharmaceutical intermediates, high-quality APIs, high-end preparations to the commercial sector, and has a number of domestic exclusive varieties, and a number of leading varieties are in the forefront of the world, of which the annual production capacity of APIs has reached 50,000 tons, the supporting intermediates capacity is 500,000 tons, and the annual revenue exceeds 7.5 billion yuan.

02 Inheritance, all for the people

From its establishment to its development, Xinhua Pharmaceutical, which inherits the red gene, has always adhered to a belief - "everything is for the people". In order to achieve this goal and practice the mission of "protecting health and benefiting society", Xinhua Pharmaceutical is even willing to go against the profit "instinct" of enterprise development and sacrifice its vital interests.

In Xinhua Pharmaceutical, there is a drug that not only has no sales profit, but even has to put money into it, which is Xinhua Pharmaceutical's exclusive product acetamide injection. Acetamide injection is a special antidote for poisoning such as organofluorine insecticides and rodenticides fluoroacetamide, because of its short shelf life and few uses, this drug not only has no sales profit, but even loses money.

However, for patients who are unfortunate enough to be poisoned, it is an out-and-out life-saving medicine.

In the past few years, Xinhua Pharmaceutical has frequently reported that drugs have been delivered thousands of miles away. In 1995, Xinhua Pharmaceutical sent medicine thousands of miles to save nearly 300 poisoned patients in Pingchuan District, ** City, Gansu ProvinceIn 2007, 203 poisoned patients from the Heilongjiang Provincial Institute of Traditional Chinese Medicine were rescuedIn 2011, he urgently delivered medicine to the victims of the vicious poisoning incident in Tangshan, Hebei ProvinceIn 2019, Baili urgently sent life-saving medicine to rescue the 19-month-old baby girl Xiao Muqi;In 2021, Xinhua Pharmaceutical employees traveled 300 kilometers to Huai'an to deliver medicines to patients.

At present, in China, only Xinhua Pharmaceutical still insists on producing this life-saving drug and has not stopped related research and development. In March this year, Xinhua Pharmaceutical's acetamide chemical API was also approved for marketing.

For Xinhua Pharmaceutical, a "red pharmaceutical company", the "righteousness" of benefiting the society is higher than the "small profit" of the company itself.

In 2008, "512. "Wenchuan ** pulls the hearts of the people of the whole country. **More than 10 hours after the incident, Xinhua Pharmaceutical's first batch of emergency donations of 600,000 yuan of first-aid drugs were airdropped to the Wenchuan disaster area at the first time, and then a total of more than 320 yuan of drugs were donated to the disaster area. In 2008 "428 "Jiaoji Railway Accident, 2010" 414. In major events such as Yushu**, Xinhua Pharmaceutical also actively donated caring drugs, demonstrating the moral and social responsibility of the enterprise.

Xinhua Pharmaceutical won the "China Pharmaceutical Corporate Social Responsibility Contribution Award", and is the "National Enterprise Supporting Public Welfare Undertakings and Caring for the Health of the People", the Advanced Collective of Unpaid Blood Donation in Shandong Province, and the Most Caring Enterprise of Zibo Charity Award.

03 Take responsibility and go all out to protect **

Within a week, the daily production capacity of ibuprofen was expanded by 17 times, which is another miracle created by Xinhua Pharmaceutical.

Last winter, there was a shortage of antipyretic and analgesic drugs in many places across the country, and ibuprofen was even more difficult to find. In the "Reference Table of Commonly Used Drugs for Novel Coronavirus Infected Patients at Home", ibuprofen, acetaminophen, aspirin, loratadine, cetirizine and other drugs produced by Xinhua Pharmaceutical are listed.

As the world's largest ibuprofen API production base and a veteran state-owned enterprise, Xinhua Pharmaceutical took urgent action.

Including the scientific research personnel of the research institute, more than 1,000 employees of Xinhua Pharmaceutical rushed to the production line, ate and lived in the factory, and a number of intelligent production lines were in full production 24 hours a day, with a total of more than 1,000 tons of ibuprofen APIs. At the same time, urgently needed drugs such as ibuprofen tablets and vitamin C tablets have also increased production and expanded production, stepped up the market, and stabilized social demand.

This drug defense war has also closely connected enterprises, regulatory departments and the people.

Previously, the main packaging size of ibuprofen produced by Xinhua Pharmaceutical was 100 tablets. In order to allow more people to use the urgently needed drugs as soon as possible, Xinhua Pharmaceutical urgently submitted a small size aluminum-plastic packaging of 12 tablets for the record. Many departments of the Shandong Biopharmaceutical Administration stepped up coordination, intervened in advance from data declaration to process inspection, stability inspection and other links, and finally completed the approval process of the new packaging specification in only 4 hours, so that more people can use the assured drug.

From scratch to excellence, Xinhua Pharmaceutical has led the development of China's chemical and pharmaceutical industryGiving up small profits and undertaking great righteousness, Xinhua Pharmaceutical continues to seek benefits for the people;Responding positively and having the courage to undertake, Xinhua Pharmaceutical has gone all out to protect people's livelihood and protect the best people.

The red spirit has been deeply rooted in the blood of Xinhua Pharmaceutical. Whenever the country and the people need it, Xinhua Pharmaceutical will stand up, face difficulties, assume the responsibility of state-owned enterprises, and practice the mission of "protecting health and benefiting society".

Text: Xiaoyang).

Related Pages